Neural Control of Hepatic Lipid Metabolism


Book Description

"Our body is well designed to store energy in times of nutrient excess and release energy in times of need. This adaptation to the external environment is achieved by both humoral factors and the autonomic nervous system. Already in the 19th century, Claude Bernard pointed out the importance of the autonomic nervous system in the control of glucose metabolism. In the next century, the discovery of insulin and the development of techniques to measure hormone concentrations shifted the focus of the control of metabolism to the secretion of hormones, thus functionally "decapitating" the body. Just before the end of the 20th century, starting with the discovery of leptin in 1994, the control of energy metabolism went back to our heads. Today, the autonomic nervous system is acknowledged as one of the important determinants of liver metabolism and as a possible treatment target. This thesis investigates the role of the autonomic nervous system in the control of hepatic lipid metabolism during different physiological conditions. We found that the sympathetic and parasympathetic nervous system represent complimentary forces, fine-tuning hepatic lipid metabolism during different nutritional states."--Samenvatting auteur.




Neural Regulation of Metabolism


Book Description

This book systemically describes the mechanisms underlying the neural regulation of metabolism. Metabolic diseases, including obesity and its associated conditions, currently affect more than 500 million people worldwide. Recent research has shown that the neural regulation of metabolism is a central mechanism that controls metabolic status physiologically and pathophysiologically. The book first introduces the latest studies on the neural and cellular mechanisms of hypothalamic neurons, hypothalamic glial cells, neural circuitries, cellular signaling pathways, and synaptic plasticity in the control of appetite, body weight, feeding-related behaviors and metabolic disorders. It then summarizes the humoral mechanisms by which critical adipocyte-derived hormones and lipoprotein lipase regulate lipid and glucose metabolism, and examines the role of the hypothalamus-sympathetic nerve, a critical nerve pathway from CNS to peripheral nervous system (PNS), in the regulation of metabolism in multiple tissues/organs. Furthermore, the book discusses the functions of adipose tissue in energy metabolism. Lastly, it explores dietary interventions to treat neural diseases and some of the emerging technologies used to study the neural regulation of metabolism. Presenting cutting-edge developments in the neural regulation of metabolism, the book is a valuable reference resource for graduate students and researchers in the field of neuroscience and metabolism.




Liver Innervation and the Neural Control of Hepatic Function


Book Description

In the liver, nutrients taken up from food are utilized for the synthesis of different components of the body, and the waste matter and harmful substances produced are disposed or detoxicated. These functions of the liver must be regulated in accordance with the state of the body. The nervous system plays this regulatory role, one which is reminiscent of the production management system in a factory.




Novel Roles of GLP-1 and GLP-2 in the Regulation of Hepatic Lipid/Lipoprotein Homeostasis and the Involvement of BAT Activation


Book Description

Major complications of insulin resistance and type 2 diabetes (T2D) include the development of non-alcoholic fatty liver disease (NAFLD) and an atherogenic fasting dyslipidemic profile, primarily due to increases in hepatic very low density lipoprotein (VLDL) production. Recent studies have implicated neuronal signalling in the control of hepatic lipid metabolism and VLDL production. The gut derived hormones glucagon-like peptide (GLP)-1 and GLP-2 have been shown to signal through neuronal pathways and display postprandial hypolipidemic and hyperlipidemic actions respectively. Furthermore, activation of brown adipose tissue (BAT) through the sympathetic nervous system also displays hypolipidemic actions and has recently been shown to be activated by GLP-1. We hypothesized that GLP-1 and GLP-2 will play opposing roles by decreasing and increasing VLDL production and NAFLD respectively. We further hypothesized that the effects of GLP-1 in modulating lipid metabolism occur through the activation of BAT. Using the Syrian Golden hamster, we showed that the GLP-1 receptor (GLP-1R) agonist exendin-4 decreased body weight, fasting dyslipidemia and VLDL overproduction by enhancing lipid utilization and decreasing hepatic de novo lipogenesis. These effects occurred through a vagal signalling pathway and were independent of changes in food consumption. To assess the involvement of BAT in the hypolipidemic actions of GLP-1, we first characterized the hamster as a novel and effective model of BAT activation. Î ̨3-adrenergic receptor (Î ̨3-AR) agonism activated hamster BAT, induced browning of WAT and prevented diet-induced NAFLD. The hypolipidemic actions of GLP-1R agonism were partially mediated by BAT as shown in hamsters that underwent BAT removal. Conversely, the sister peptide GLP-2 increased VLDL production and hepatic steatosis in hamsters and mice. Interestingly, GLP-2R knockout (KO) mice were protected against diet-induced dyslipidemia but displayed enhanced hepatic lipid accumulation. An observed reduction in VLDL-TG levels indicated that the enhanced hepatic lipid levels may be due to decreased VLDL production. Taken together, this thesis demonstrates that GLPs play critical but opposing roles in regulating hepatic lipid accumulation and VLDL production. Modulating the balance of GLPs in vivo may be a potential therapeutic approach to correct the dyslipidemia and NAFLD commonly associated with the metabolic syndrome.







Transcriptional Control of Hepatic Metabolism in Physiology


Book Description

Liver is a key regulator of systemic metabolism in physiology and pathology. It maintains cholesterol, triglyceride and glucose homeostasis in response to fasting and feeding. Transcription factors responsive to hormones and nutrients coordinate many of these responses. They regulate gene networks relating to lipid, glucose and amino acid metabolism during fasting and feeding, and factors such as sex, circadian rhythms and dietary content interact with these transcriptional programs, as reviewed in chapter 1. Understanding the different players in these processes and how they interact with each other will be key to develop strategies to combat metabolic diseases. Recent advances in probing the transcriptional landscape, coupled with high throughput sequencing approaches such as assay for transposase accessible chromatin (ATAC-Seq), have enabled the identification of transcriptional regulators of these processes and their interrelationships. In chapter 2, I describe results from a screen using ATAC-Seq and RNA-Seq to profile novel transcriptional regulators of the hepatic response to fasting and feeding. We determined GATA4 expression and activity to be upregulated by feeding through insulin. Knocking out Gata4 in adult liver impaired the transcriptional and metabolic response to feeding. Additionally, loss of hepatic GATA4 led to a reduction in HDL cholesterol and to the accumulation of liver triglycerides. These effects were accompanied by the downregulation of genes involved in cholesterol efflux and triglyceride hydrolysis, and the upregulation of genes involved in lipid uptake. Furthermore, hepatic GATA4 colocalized and collaborated with Liver X Receptor (LXR), a key regulator of cholesterol transport. In chapter 3, I investigated the dynamics of hepatic LXRs via ATAC-Seq and RNA-Seq in wild-type and LXR[alpha]/[Beta] knockout liver. Loss of LXRs in liver changed the transcriptional regulatory landscape by reducing accessibility at enhancers and increasing accessibility at promoters. A broad set of transcription factors that bind enhancers, including nuclear receptors, had reduced activity based on their motif accessibility, showing their reliance on LXRs. Moreover, this investigation demonstrated that LXR also functions as a transcriptional repressor of certain genes. Overall, these studies revealed important functions for GATA4 and LXR within hepatic transcriptional networks, extending our understanding of transcriptional regulation of hepatic lipid metabolism.




Anatomy and Physiology


Book Description




Fat Detection


Book Description

Presents the State-of-the-Art in Fat Taste TransductionA bite of cheese, a few potato chips, a delectable piece of bacon - a small taste of high-fat foods often draws you back for more. But why are fatty foods so appealing? Why do we crave them? Fat Detection: Taste, Texture, and Post Ingestive Effects covers the many factors responsible for the se




The Liver in Systemic Diseases


Book Description

Based on the results of studies on autoimmunity, the endocrine system, nutrients, metal metabolism and intestinal bacterial flora, this volume thoroughly covers studies on functional correlation of the liver with the spleen, visceral fat, intestinal tract, and central nervous system. Including associations with dysbiosis, nonalcoholic steatohepatitis (NASH) and hepatocellular carcinoma, it offers comprehensive data on correlations of organs with the liver from basic and clinical viewpoints. The Liver in Systemic Diseases will especially be of interest to researchers, clinical residents and medical students with an interest in hepatology and gastroenterology. Furthermore, the book has interdisciplinary appeal and provides a foundation that will help physicians to consider clinical conditions of diseases from a broader perspective.




Liver and Nervous System


Book Description

Proceedings of the Falk Symposium 103, held in Freiburg, Germany, on October 4-5, 1997.